Induction of humoral and cellular immune responses by antigen-expressing immunostimulatory liposomes

Journal of Controlled Release

Volumn 164, Issue 3, 2012, Pages 323-330

  Amidi, Maryam ^a   Van Helden, Mary J G ^b   Tabataei, Neda Rafiei ^a   De Goede, Anna L ^c   Schouten, Marijn ^a   De Bot, Volkert ^a   Lanzi, Anastasia ^a   Gruters, Rob A ^c   Rimmelzwaan, Guus F ^c   Sijts, Alice J A M ^b   Mastrobattista, Enrico ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Cell free protein synthesis; Cell mediated immunity; DNA vaccines

Indexed keywords

CELL FREE PROTEIN SYNTHESIS; CELL-MEDIATED IMMUNITY; CMV PROMOTER; DNA VACCINE; DOSE-DEPENDENT; IMMUNE RESPONSE; LOW LEVEL; PLASMID VECTORS; T-CELL RESPONSE; TETRAMERS;

CELLS; CYTOLOGY; DRUG THERAPY; LIPOSOMES; MAMMALS; MOLECULAR BIOLOGY; OLIGOMERS; VACCINES;

ANTIGENS;

ANTIGEN; BETA GALACTOSIDASE; DNA VACCINE; LIPOSOME; PLASMID DNA;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIGEN PRESENTING CELL; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONFERENCE PAPER; FEMALE; HUMORAL IMMUNITY; IMMUNOSTIMULATION; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; T LYMPHOCYTE ACTIVATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIGENS; BETA-GALACTOSIDASE; FEMALE; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; LIPOSOMES; LUCIFERASES; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; PLASMIDS; T-LYMPHOCYTES; VACCINES, DNA;

EID: 84870242102     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2012.08.016     Document Type: Conference Paper

References (39)

1. J. Pulido, T. Kottke, J. Thompson, F. Galivo, P. Wongthida, R.M. Diaz, D. Rommelfanger, E. Ilett, L. Pease, and H. Pandha Using virally expressed melanoma cDNA libraries to identify tumor-associated antigens that cure melanoma Nat. Biotechnol. 30 2012 337 343
2. F. Saade, and N. Petrovsky Technologies for enhanced efficacy of DNA vaccines Expert Rev. Vaccines 11 2012 189 209
3. M.A. Liu DNA vaccines: an historical perspective and view to the future Immunol. Rev. 239 2011 62 84
4. F.K. Stevenson, C.H. Ottensmeier, and J. Rice DNA vaccines against cancer come of age Curr. Opin. Immunol. 22 2010 264 270
5. M. Corr, D.J. Lee, D.A. Carson, and H. Tighe Gene vaccination with naked plasmid DNA: mechanism of CTL priming J. Exp. Med. 184 1996 1555 1560
6. M. Amidi, M. de Raad, D.J. Crommelin, W.E. Hennink, and E. Mastrobattista Antigen-expressing immunostimulatory liposomes as a genetically programmable synthetic vaccine Syst. Synth. Biol. 5 2011 21 31
7. M. Amidi, M. de Raad, H. de Graauw, D. van Ditmarsch, W.E. Hennink, D.J. Crommelin, and E. Mastrobattista Optimization and quantification of protein synthesis inside liposomes J. Liposome Res. 20 2010 73 83
8. P. Pala, A.R. Townsend, and B.A. Askonas Viral recognition by influenza A virus cross-reactive cytotoxic T (Tc) cells: the proportion of Tc cells that recognize nucleoprotein varies between individual mice Eur. J. Immunol. 16 1986 193 198
9. A.R. Townsend, J. Rothbard, F.M. Gotch, G. Bahadur, D. Wraith, and A.J. McMichael The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides Cell 44 1986 959 968
10. A.D. Bins, A. Jorritsma, M.C. Wolkers, C.F. Hung, T.C. Wu, T.N. Schumacher, and J.B. Haanen A rapid and potent DNA vaccination strategy defined by in vivo monitoring of antigen expression Nat. Med. 11 2005 899 904
11. D. Schweichel, J. Steitz, D. Tormo, E. Gaffal, A. Ferrer, S. Buchs, P. Speuser, A. Limmer, and T. Tuting Evaluation of DNA vaccination with recombinant adenoviruses using bioluminescence imaging of antigen expression: impact of application routes and delivery with dendritic cells J. Gene Med. 8 2006 1243 1250
12. C. Curcio, A.S. Khan, A. Amici, M. Spadaro, E. Quaglino, F. Cavallo, G. Forni, and R. Draghia-Akli DNA immunization using constant-current electroporation affords long-term protection from autochthonous mammary carcinomas in cancer-prone transgenic mice Cancer Gene Ther. 15 2008 108 114
13. D.J. Hulse, and C.H. Romero Partial protection against infectious bursal disease virus through DNA-mediated vaccination with the VP2 capsid protein and chicken IL-2 genes Vaccine 22 2004 1249 1259
14. H. Potter, and R. Heller Transfection by Electroporation Current Protocols in Neuroscience 2001 John Wiley & Sons, Inc.
15. S.A. Rosenberg, J.C. Yang, R.M. Sherry, P. Hwu, S.L. Topalian, D.J. Schwartzentruber, N.P. Restifo, L.R. Haworth, C.A. Seipp, L.J. Freezer, K.E. Morton, S.A. Mavroukakis, and D.E. White Inability to immunize patients with metastatic melanoma using plasmid DNA encoding the gp100 melanoma-melanocyte antigen Hum. Gene Ther. 14 2003 709 714
16. Y.Z. Zhai, X.M. Li, Y. Zhou, L. Ma, and G.H. Feng Intramuscular immunization with a plasmid DNA vaccine encoding prM-E protein from Japanese encephalitis virus: enhanced immunogenicity by co-administration of GM-CSF gene and genetic fusions of prM-E protein and GM-CSF Intervirology 52 2009 152 163
17. L. Gissmann HPV vaccines: preclinical development Arch. Med. Res. 40 2009 466 470
18. Gloria Y.F. Ho, Y. Studentsov, Charles B. Hall, R. Bierman, L. Beardsley, M. Lempa, and Robert D. Burk Risk factors for subsequent cervicovaginal human papillomavirus (HPV) infection and the protective role of antibodies to HPV-16 virus-like particles J. Infect. Dis. 186 2002 737 742
19. D. Montefiori, Q. Sattentau, J. Flores, J. Esparza, J. Mascola, and W.G.C.G.H. Va Antibody-based HIV-1 vaccines: recent developments and future directions PLoS Med. 4 2007 1867 1871
20. D.C. Montefiori, and J.R. Mascola Neutralizing antibodies against HIV-1: can we elicit them with vaccines and how much do we need? Curr. Opin. HIV AIDS 4 2009 347 351 10.1097/COH.0b013e32832f4a4d
21. Q. Sattentau Correlates of antibody-mediated protection against HIV infection Curr. Opin. HIV AIDS 3 2008 368 374
22. L.A. Smith Botulism and vaccines for its prevention Vaccine 27 2009 D33 D39
23. J.P. Coutelier, J.T. van der Logt, F.W. Heessen, G. Warnier, and J. Van Snick IgG2a restriction of murine antibodies elicited by viral infections J. Exp. Med. 165 1987 64 69
24. M.J. Hocart, J.S. Mackenzie, and G.A. Stewart The immunoglobulin G subclass responses of mice to influenza A virus: the effect of mouse strain, and the neutralizing abilities of individual protein A-purified subclass antibodies J. Gen. Virol. 70 Pt 9 1989 2439 2448
25. A.O. Hovden, R.J. Cox, A. Madhun, and L.R. Haaheim Two doses of parenterally administered split influenza virus vaccine elicited high serum IgG concentrations which effectively limited viral shedding upon challenge in mice Scand. J. Immunol. 62 2005 342 352
26. J. Imoto, and E. Konishi Needle-free jet injection of a mixture of Japanese encephalitis DNA and protein vaccines: a strategy to effectively enhance immunogenicity of the DNA vaccine in a murine model Viral Immunol. 18 2005 205 212
27. N. Mushenkova, E. Moiseeva, A. Chaadaeva, W. Den Otter, and E. Svirshchevskaya Antitumor effect of double immunization of mice with mucin 1 and its coding DNA Anticancer Res. 25 2005 3893 3898
28. E. Konishi, A. Terazawa, and J. Imoto Simultaneous immunization with DNA and protein vaccines against Japanese encephalitis or dengue synergistically increases their own abilities to induce neutralizing antibody in mice Vaccine 21 2003 1826 1832
29. M. Krupa, M. Canamero, C.E. Gomez, J.L. Najera, J. Gil, and M. Esteban Immunization with recombinant DNA and modified vaccinia virus Ankara (MVA) vectors delivering PSCA and STEAP1 antigens inhibits prostate cancer progression Vaccine 29 2011 1504 1513
30. C. Ranasinghe, F. Eyers, J. Stambas, D.B. Boyle, I.A. Ramshaw, and A.J. Ramsay A comparative analysis of HIV-specific mucosal/systemic T cell immunity and avidity following rDNA/rFPV and poxvirus-poxvirus prime boost immunisations Vaccine 29 2011 3008 3020
31. P. Laing, A. Bacon, B. McCormack, G. Gregoriadis, B. Frisch, and F. Schuber The 'co-delivery' approach to liposomal vaccines: application to the development of influenza-A and hepatitis-B vaccine candidates J. Liposome Res. 16 2006 229 235
32. H. Jin, Y. Kang, L. Zhao, C. Xiao, Y. Hu, R. She, Y. Yu, X. Du, G. Zhao, T. Ng, H.J. Chu, and B. Wang Induction of adaptive T regulatory cells that suppress the allergic response by coimmunization of DNA and protein vaccines J. Immunol. 180 2008 5360 5372
33. J. Jin, Z. Ding, F. Meng, Q. Liu, T. Ng, Y. Hu, G. Zhao, B. Zhai, H.J. Chu, and B. Wang An immunotherapeutic treatment against flea allergy dermatitis in cats by co-immunization of DNA and protein vaccines Vaccine 28 2010 1997 2004
34. F. Junge, S. Haberstock, C. Roos, S. Stefer, D. Proverbio, V. Dotsch, and F. Bernhard Advances in cell-free protein synthesis for the functional and structural analysis of membrane proteins New Biotechnol. 28 3 2011 262 271
35. M.A. Goren, A. Nozawa, S. Makino, R.L. Wrobel, and B.G. Fox Cell-free translation of integral membrane proteins into unilamelar liposomes Methods Enzymol. 463 2009 647 673
36. Y. Kuruma, T. Suzuki, and T. Ueda Production of multi-subunit complexes on liposome through an E. coli cell-free expression system Methods Mol. Biol. 607 2010 161 171
37. Y. Moritani, S.I. Nomura, I. Morita, and K. Akiyoshi Direct integration of cell-free-synthesized connexin-43 into liposomes and hemichannel formation FEBS J. 277 16 2010 3343 3352
38. A. Nozawa, H. Nanamiya, and Y. Tozawa Production of membrane proteins through the wheat-germ cell-free technology Methods Mol. Biol. 607 2010 213 218
39. S. Reckel, S. Sobhanifar, F. Durst, F. Lohr, V.A. Shirokov, V. Dotsch, and F. Bernhard Strategies for the cell-free expression of membrane proteins Methods Mol. Biol. 607 2010 187 212